+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

How common are common fragile sites in humans: interindividual variation in the distribution of aphidicolin-induced fragile sites



How common are common fragile sites in humans: interindividual variation in the distribution of aphidicolin-induced fragile sites



Cytogenetic and Genome Research 101(1): 8-16



To obtain an estimate of the variation in common fragile sites (CFSs) among individuals, aphidicolin (APC)-induced chromosomal breakage data were analyzed for 20 karyotypically normal adult humans. As it is specifically designed to meet the analytical requirements for considering fragile sites as presence/absence characters in single individuals, the FSM methodology (Böhm et al., 1995) was used to statistically distinguish fragile from nonfragile sites. These analyses indicated that the APC-induced fragile sites are not ubiquitous but vary extensively among individuals; the per-individual number of fragile sites ranged from as few as seven to as many as 20. Of the 45 different sites identified as fragile, 19 (42%) occurred in more than half of the individuals, but only two sites (3p14 and 16q23) were fragile in all of the individuals; 12 (27% of the total) were fragile in single individuals only. Although these analyses provide statistical confirmation (and initial estimates of population variation) for 43 of the 88 APC-inducible fragile sites currently recognized as occurring among humans, they are consistent with the hypothesis that many of the currently recognized human CFSs have been erroneously identified. These results indicate the need for per-individual statistical identification of CFSs for larger samples of individuals and that studies of particular fragile sites should be conducted on individuals documented to be fragile at the loci under consideration.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 012156830

Download citation: RISBibTeXText

PMID: 14571130

DOI: 10.1159/000073411


Related references

How common are common fragile sites: Variation of aphidicolin-induced chromosomal fragile sites in a population of the deer mouse (Peromyscus maniculatus). Human Genetics 100(2): 182-188, 1997

Common fragile sites induced by folate deprivation, BrdU and aphidicolin: their frequency and distribution in Japanese individuals. Jinrui Idengaku Zasshi. Japanese Journal of Human Genetics 33(3): 355-364, 1988

Fibroblast-specific common fragile sites induced by aphidicolin. Human Genetics 83(1): 45-48, 1989

Cancer chromosome breakpoints and common fragile sites induced by aphidicolin. Cancer Genetics and Cytogenetics 13(2): 185-188, 1984

Increased expression of aphidicolin-induced common fragile sites in Tourette syndrome: the key to understand the genetics of comorbid phenotypes?. American Journal of Medical Genetics 67(1): 25-30, 1996

Reduced expression of aphidicolin-induced common fragile sites in peripheral lymphocyte chromosomes of patients with B-cell chronic lymphocytic leukemia. Cancer Genetics and Cytogenetics 39(1): 99-102, 1989

Synergistic effect of aphidicolin and ethanol on the induction of common fragile sites. Human Genetics 75(1): 75-78, 1987

Population cytogenetics of folate-sensitive fragile sites. I. Common fragile sites. Human Genetics 80(4): 344-348, 1988

Aphidicolin-sensitive specific common fragile sites: a biomarker of exposure to pesticides. Environmental and Molecular Mutagenesis 29(3): 250-255, 1997

Expression of common fragile sites in untreated non-Hodgkin's lymphoma with aphidicolin and folate deficiency. Cancer Letters 86(1): 111-117, 1994

Conservation of aphidicolin-induced fragile sites in Papionini (Primates) species and humans. Chromosome Research 12(7): 683-690, 2004

The Expression of Common Fragile Sites in Peripheral Blood Lymphocytes of Breast and Colorectal Cancer Patients with Aphidicolin. The Tohoku Journal of Experimental Medicine 189(2): 107-116, 1999

The expression of common fragile sites in peripheral blood lymphocytes of breast and colorectal cancer patients with aphidicolin. Tohoku Journal of Experimental Medicine 189(2): 107-116, 2000

DNA polymerase alpha inhibition by aphidicolin induces gaps and breaks at common fragile sites in human chromosomes. Human Genetics 67(2): 136-142, 1984

Variation in the expression of aphidicolin-induced fragile sites in human lymphocyte cultures. Human Genetics 76(2): 134-137, 1987